DRUG-RESISTANCE OF SECONDARY ACUTE MYELOID-LEUKEMIA WITH MEGAKARYOBLASTIC FEATURES AND P190 BCR-ABL REARRANGEMENT

Citation
H. Veelken et al., DRUG-RESISTANCE OF SECONDARY ACUTE MYELOID-LEUKEMIA WITH MEGAKARYOBLASTIC FEATURES AND P190 BCR-ABL REARRANGEMENT, Leukemia research, 22(11), 1998, pp. 1021-1027
Citations number
28
Categorie Soggetti
Oncology,Hematology
Journal title
ISSN journal
01452126
Volume
22
Issue
11
Year of publication
1998
Pages
1021 - 1027
Database
ISI
SICI code
0145-2126(1998)22:11<1021:DOSAMW>2.0.ZU;2-B
Abstract
A 46-year-old female presented with acute myeloid leukemia during comp lete remission of multiple myeloma after extensive treatment with alky lating agents. Leukemic blasts expressed CD34, platelet esterase and g p IIIa. RT-PCR analyses of peripheral blood cells detected a p190 type BCR-ABL rearrangement and high levels of MDR1. The patient expired du ring neutropenia shortly after induction chemotherapy. Autopsy reveale d persistent blasts in the bone marrow, spleen and liver. 'Secondary' acute myeloid leukemia with megakaryoblastic features and p190-type BC R-ABL rearrangement has not previously been reported. The possibility that the combination of a BCR-ABL rearrangement with overexpression of MDR1 may have contributed to the treatment-refractory course is discu ssed. (C) 1998 Elsevier Science Ltd. All rights reserved.